China National Medicines Corporation Ltd. (SHA:600511)
China · Delayed Price · Currency is CNY 29.23
+0.10 (0.34%)
At close: Feb 6, 2026
SHA:600511 Revenue
China National Medicines Corporation had revenue of 13.75B CNY in the quarter ending September 30, 2025, with 3.58% growth. This brings the company's revenue in the last twelve months to 51.95B, up 1.48% year-over-year. In the year 2024, China National Medicines Corporation had annual revenue of 50.60B with 1.81% growth.
Revenue (ttm)
51.95B
Revenue Growth
+1.48%
P/S Ratio
0.42
Revenue / Employee
16.74M
Employees
3,104
Market Cap
22.05B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 50.60B | 901.40M | 1.81% |
| Dec 31, 2023 | 49.70B | 4.20B | 9.23% |
| Dec 31, 2022 | 45.50B | -970.02M | -2.09% |
| Dec 31, 2021 | 46.47B | 6.09B | 15.08% |
| Dec 31, 2020 | 40.38B | -4.27B | -9.56% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shanghai Pharmaceuticals Holding | 280.69B |
| Jointown Pharmaceutical Group | 157.71B |
| C.Q. Pharmaceutical Holding | 83.08B |
| Guangzhou Baiyunshan Pharmaceutical Holdings Company | 77.54B |
| China National Accord Medicines Corporation | 73.04B |
| China Meheco Group | 33.23B |
| Guangxi LiuYao Group | 20.95B |
| Liaoning Cheng Da | 11.12B |